Nexien BioPharma, Inc.
NXEN · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$30 | -$39 | -$32 | -$87 |
| Dep. & Amort. | $4 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $10 | $5 | $15 | $13 |
| Other Non-Cash | $2 | $6 | $8 | $63 |
| Operating Cash Flow | -$13 | -$29 | -$9 | -$11 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $20 | $25 | $0 | $33 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $10 | -$28 |
| Financing Cash Flow | $20 | $25 | $10 | $5 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $7 | -$4 | $1 | -$6 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1 | $5 | $4 | $10 |
| End Cash | $8 | $1 | $5 | $4 |
| Free Cash Flow | -$13 | -$29 | -$9 | -$11 |